Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Number of items: 11.

Koushyar, Sarah, Uysal-Onganer, Pinar, Jiang, Wen G. ORCID: and Dart, D. Alwyn 2023. Prohibitin links cell cycle, motility and invasion in Prostate Cancer cells. International Journal of Molecular Sciences 24 , 9919. 10.3390/ijms24129919

Bates, Emily A., Davies, James A. ORCID:, Vánová, Jana, Nestic, Davor, Meniel, Valerie S., Koushyar, Sarah, Cunliffe, Tabitha G., Mundy, Rosie M., Moses, Elise, Uusi-Kerttula, Hanni K., Baker, Alexander T. ORCID:, Cole, David K. ORCID:, Majhen, Dragomira, Rizkallah, Pierre J. ORCID:, Phesse, Toby ORCID:, Chester, John D. ORCID: and Parker, Alan L. ORCID: 2022. Development of a low seroprevalence, αvβ6 integrin selective virotherapy based on human adenovirus type 10. Molecular Therapy - Oncolytics 25 , pp. 43-56. 10.1016/j.omto.2022.03.007

Koushyar, Sarah, Meniel, Valerie S., Phesse, Toby J. ORCID: and Pearson, Helen B. ORCID: 2022. Exploring the Wnt pathway as a therapeutic target for prostate cancer. Biomolecules 12 (2) , 309. 10.3390/biom12020309

Koushyar, Sarah, Powell, Arfon G. ORCID:, Vincan, Elizabeth and Phesse, Toby J. ORCID: 2020. Targeting Wnt signaling for the treatment of gastric cancer. International Journal of Molecular Sciences 21 (11) , 3927. 10.3390/ijms21113927

Dart, D. Alwyn, Koushyar, Sarah, Lanning, Ben.E and Jiang, Wenguo ORCID: 2019. MiR-221 is specifically elevated in PC3 cells and its deletion reduces adhesion, motility and growth. Anticancer Research 39 (10) , pp. 5311-5327. 10.21873/anticanres.13724

Flanagan, Dustin J., Barker, Nick, Di Costanzo, Natasha S., Mason, Elizabeth A., Gurney, Austin, Meniel, Valerie S., Koushyar, Sarah, Austin, Chloe R., Ernst, Matthias, Pearson, Helen B. ORCID:, Boussioutas, Alex, Clevers, Hans, Phesse, Toby J. ORCID: and Vincan, Elizabeth 2019. Frizzled-7 is required for Wnt signaling in gastric tumours with and without Apc mutations. Cancer Research 79 (5) , pp. 970-981. 10.1158/0008-5472.CAN-18-2095

Pearson, Helen B. ORCID:, Li, Jason, Meniel, Valerie S., Fennell, Christina M., Waring, Paul, Montgomery, Karen G., Rebello, Richard J., Macpherson, Arthi A., Koushyar, Sarah, Furic, Luc, Cullinane, Carleen, Clarkson, Richard W. ORCID:, Smalley, Matthew J. ORCID:, Simpson, Kaylene J., Phesse, Toby J. ORCID:, Shepherd, Peter R., Humbert, Patrick O., Sansom, Owen J. and Phillips, Wayne A. 2018. Identification of Pik3ca mutation as a genetic driver of prostate cancer that cooperates with Pten loss to accelerate progression and castration-resistant growth. Cancer Discovery 8 (6) , pp. 764-779. 10.1158/2159-8290.CD-17-0867

Koushyar, Sarah, Economides, G, Zaat, Sharlene, Jiang, Wen ORCID:, Bevan, Charlotte L. and Dart, Alwyn 2017. The prohibitin-repressive interaction with E2F1, is rapidly inhibited by androgen signalling in prostate cancer cells. Oncogenesis 6 , e3333. 10.1038/oncsis.2017.32

Koushyar, Sarah 2017. Mechanisms involved in the development of androgen independent prostate: Androgen receptor activation leads to a dissociation of E2F1:PHB in prostate cancer. PhD Thesis, Cardiff University.
Item availability restricted.

Koushyar, Sarah, Grant, Guy and Uysal-Onganer, Pinar 2016. The interaction of wnt-11 and signalling cascades in prostate cancer. Tumour Biology 10.1007/s13277-016-5263-z

Koushyar, Sarah, Jiang, Wen Guo ORCID: and Dart, Dafydd Alwyn 2015. Unveiling the potential of prohibitin in cancer. Cancer Letters 369 (2) , pp. 316-322. 10.1016/j.canlet.2015.09.012

This list was generated on Tue Jul 23 13:14:58 2024 BST.